Newsroom
Sorted by: Latest
-
Ferguson Enterprises Inc. (“Company”): Execution of Rule 10b5-1 Plan
NEWPORT NEWS, Va.--(BUSINESS WIRE)--This is an initial notification of a transaction of a person discharging managerial responsibility (“PDMR”) in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018). The Company announces that Kevin Murphy, President & Chief Executive Officer, entered into a Rule 10b5-1 plan in respect of common stock of par value $0.0001 each in the Company (“Shares”) (ISIN US3...
-
Ferguson Enterprises Inc. UK Regulatory Announcement: Ferguson Enterprises Inc. (“Company”): Execution of Rule 10b5-1 Plan
NEWPORT NEWS, Va.--(BUSINESS WIRE)-- This is an initial notification of a transaction of a person discharging managerial responsibility (“PDMR”) in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018). The Company announces that Kevin Murphy, President & Chief Executive Officer, entered into a Rule 10b5-1 plan in respect of common stock of par value $0.0001 each in the Company (“Shares”) (ISIN U...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 08.06.2026 FKU IE00B8X9NZ57 206,700.00 GBP 8,733,992.12 42.254 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 08.06.2026 FEUD IE00BF2FL590 340,510.00 EUR 19,423,682.29 57.043 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 08.06.2026 FEUZ IE00B8X9NY41 1,601,594.00 EUR 103,130,163.01 64.392 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 08.06.2026 FEM IE00B8X9NX34 325,002.00 USD 15,818,830.38 48.673 ...
-
Fresh Del Monte Produce Inc. Announces Name Change to Del Monte Corporation and NYSE Ticker Symbol Change to “DMC”
CORAL GABLES, Fla.--(BUSINESS WIRE)--Fresh Del Monte Produce Inc. (NYSE: FDP) today announced that shareholders have approved the change of its corporate name to Del Monte Corporation, marking the next step in the company’s evolution following its previously announced acquisition of select assets of Del Monte Foods Corporation II Inc. and its affiliates. The corporate name change becomes effective today on June 9, 2026. In connection with the name change, the company will also change its New Yo...
-
Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the four‑year follow‑up data from the First-in-Human BIOMAG™-I Clinical Study (NCT04157153)* presented at the EuroPCR conference in Paris, France by Prof. Jan Torzewski (Klinikverbund Allgäu, Germany). Conducted exclusively across European centers and enrolling 116 patients, the study continues to demonstrate a favorable long‑term safety profile1, with no new cardia...
-
AdvanCell verstärkt seine Führungsriege, um die Expansion in den USA voranzutreiben und seine globale Plattform für gezielte Alpha-Therapien auszubauen
BOSTON & BRISBANE, Australien--(BUSINESS WIRE)--AdvanCell, ein auf klinische Studien spezialisiertes Unternehmen für Radiopharmazeutika, das innovative zielgerichtete Alpha-Therapien gegen Krebs entwickelt, gab heute die Ernennung von Justyna Kelly zur Chief Technology Officer (CTO) und von François Gaudet zum Chief Scientific Officer (CSO) bekannt. Damit wird das Führungsteam des Unternehmens in den USA erweitert, während das Unternehmen seine Kapazitäten in den USA weiter ausbaut und seine wa...
-
AdvanCell renforce son équipe dirigeante afin d'accélérer son expansion aux États-Unis et développer sa plateforme mondiale d'alphathérapie ciblée
BOSTON et BRISBANE, Australie--(BUSINESS WIRE)--AdvanCell, une entreprise radiopharmaceutique en phase clinique développant des alphathérapies ciblées innovantes contre le cancer, a annoncé aujourd'hui la nomination de Justyna Kelly comme CTO et de François Gaudet comme CSO, renforçant ainsi l'équipe de direction de la société aux États-Unis à mesure qu'elle poursuit le développement de ses capacités aux États-Unis et fait progresser son portefeuille d'alphathérapies ciblées innovantes Justyna...